A New Screening Strategy for 2019 Novel Coronavirus Infection
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT04281693|
Recruitment Status : Not yet recruiting
First Posted : February 24, 2020
Last Update Posted : February 24, 2020
|Condition or disease||Intervention/treatment||Phase|
|Novel Coronavirus Infection Pneumonia||Diagnostic Test: Standard screening strategy Diagnostic Test: New screening strategy||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||230 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Identification of a New Screening Strategy for 2019 Novel Coronavirus Infection|
|Estimated Study Start Date :||February 2020|
|Estimated Primary Completion Date :||March 2020|
|Estimated Study Completion Date :||March 2020|
|Experimental: Screening participants||
Diagnostic Test: Standard screening strategy
The pharyngeal swab specimen was obtained and sent for NCIP RNA detection by individual testing.
Diagnostic Test: New screening strategy
The pharyngeal swab specimen was obtained and sent for NCIP RNA detection by minipool testing.
- Screening accuracy [ Time Frame: 1 month ]The screening accuracy of the two screening strategies were calculated and compared.
- Cost-effectiveness analysis [ Time Frame: 1 month ]The costs of the two screening strategies were recorded. Cost-effectiveness analysis were performed and compared.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04281693
|Contact: Xiaotian Sunemail@example.com|
|Contact: Zheng Lufirstname.lastname@example.org|
|the Fifth Medical Center of Chinese PLA General Hospital|
|Beijing, Beijing, China, 100071|
|Contact: Yan Liu, Ph.D. 010-66947473 email@example.com|
|Principal Investigator:||Yan Liu||The Fifth Medical Center of Chinese PLA General Hospital|